PAPER Matsui H, Takahashi R
SEARCH RESULTS
4582 RESULTS
PAPER Alafuzoff I, Libard S
Ageing-Related Neurodegeneration and Cognitive Decline.
Int J Mol Sci. 2024 Apr 5;25(7) PubMed: 38612875PAPER Lenzi P, Lazzeri G, Ferrucci M, Scotto M, Frati A, Puglisi-Allegra S, Busceti CL, Fornai F
Is There a Place for Lewy Bodies before and beyond Alpha-Synuclein Accumulation? Provocative Issues in Need of Solid Explanations.
Int J Mol Sci. 2024 Apr 1;25(7) PubMed: 38612739PAPER Imomnazarov K, Lopez-Scarim J, Bagheri I, Joers V, Tansey MG, Martín-Peña A
Biochemical Fractionation of Human α-Synuclein in a Drosophila Model of Synucleinopathies.
Int J Mol Sci. 2024 Mar 25;25(7) PubMed: 38612454PAPER McMillan IO, Gearing M, Wang L
Vascular Heparan Sulfate and Amyloid-β in Alzheimer's Disease Patients.
Int J Mol Sci. 2024 Apr 2;25(7) PubMed: 38612775PAPER Monetta L, Boland A, Macoir J, Sheppard CL, Taler V
The Quebec Semantic Memory Battery: Development, Standardization, and Psychometric Assessment of a Semantic Memory Battery in French.
Arch Clin Neuropsychol. 2024 Apr 13; PubMed: 38615178PAPER Wang X, Zhang X, Liu J, Zhang J, Liu C, Cui Y, Song Q, Hou Y, Wang Y, Zhang Q, Zhang Y, Fan Y, Jia J, Wang P
Synaptic vesicle glycoprotein 2 A in serum is an ideal biomarker for early diagnosis of Alzheimer's disease.
Alzheimers Res Ther. 2024 Apr 13;16(1):82. PubMed: 38615037PAPER Li Q, Liao Q, Qi S, Huang H, He S, Lyu W, Liang J, Qin H, Cheng Z, Yu F, Dong X, Wang Z, Han L, Han Y
Opportunities and perspectives of small molecular phosphodiesterase inhibitors in neurodegenerative diseases.
Eur J Med Chem. 2024 Apr 6;271:116386. PubMed: 38614063PAPER Yang J, Qi Y, Zhu B, Lin S
A Novel Tetrapeptide Ala-Phe-Phe-Pro (AFFP) Derived from Antarctic Krill Prevents Scopolamine-Induced Memory Disorder by Balancing Lipid Metabolism of Mice Hippocampus.
Nutrients. 2024 Mar 31;16(7) PubMed: 38613052PAPER Hsu CC, Wang SI, Lin HC, Lin ES, Yang FP, Chang CM, Wei JC
Difference of Cerebrospinal Fluid Biomarkers and Neuropsychiatric Symptoms Profiles among Normal Cognition, Mild Cognitive Impairment, and Dementia Patient.
Int J Mol Sci. 2024 Mar 31;25(7) PubMed: 38612729PAPER Pulliam L, Sun B, McCafferty E, Soper SA, Witek MA, Hu M, Ford JM, Song S, Kapogiannis D, Glesby MJ, Merenstein D, Tien PC, Freasier H, French A, McKay H, Diaz MM, Ofotokun I, Lake JE, Margolick JB, Kim EY, Levine SR, Fischl MA, Li W, Martinson J, Tang N
Microfluidic Isolation of Neuronal-Enriched Extracellular Vesicles Shows Distinct and Common Neurological Proteins in Long COVID, HIV Infection and Alzheimer's Disease.
Int J Mol Sci. 2024 Mar 29;25(7) PubMed: 38612641PAPER Kim GH, Kim BR, Yoon HJ, Jeong JH
Alterations in Gut Microbiota and Their Correlation with Brain Beta-Amyloid Burden Measured by 18F-Florbetaben PET in Mild Cognitive Impairment Due to Alzheimer's Disease.
J Clin Med. 2024 Mar 27;13(7) PubMed: 38610709PAPER Huszár Z, Engh MA, Pavlekovics M, Sato T, Steenkamp Y, Hanseeuw B, Terebessy T, Molnár Z, Hegyi P, Csukly G
Risk of conversion to mild cognitive impairment or dementia among subjects with amyloid and tau pathology: a systematic review and meta-analysis.
Alzheimers Res Ther. 2024 Apr 12;16(1):81. PubMed: 38610055PAPER Liu X, Shen L, Wan M, Xie H, Wang Z
Peripheral extracellular vesicles in neurodegeneration: pathogenic influencers and therapeutic vehicles.
J Nanobiotechnology. 2024 Apr 12;22(1):170. PubMed: 38610012PAPER Huang X, Qi J, Su Y, Zhou Y, Wang Q, Huang T, Xue D, Zeng Y, Verkhratsky A, Zhou B, Chen H, Yi C
Endothelial DR6 in blood-brain barrier malfunction in Alzheimer's disease.
Cell Death Dis. 2024 Apr 12;15(4):258. PubMed: 38609388Current Filters
- Date Range : Jan 2024 to Apr 2024 x